VIATRIS INC. Defined Benefit Plan, Funded (Unfunded) Status of Plan
VIATRIS INC. (VTRS) had Defined Benefit Plan, Funded (Unfunded) Status of Plan of $200.00 thousand as of 2025-01-01, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Funded (Unfunded) Status of Plan
us-gaap:DefinedBenefitPlanFundedStatusOfPlan · last filed 2026-08-06
- 2025-01-01: Defined Benefit Plan, Funded (Unfunded) Status of Plan $200.00K; Defined Benefit Plan, Funded (Unfunded) Status of Plan as first filed $1.80M.
| Period end | Defined Benefit Plan, Funded (Unfunded) Status of Plan | Defined Benefit Plan, Funded (Unfunded) Status of Plan as first filed |
|---|---|---|
| 2025-01-01 | $200.00K 10-Q · filed 2026-08-06 | $1.80M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |